Resectable MMR-deficient Solid Tumors
Oncology
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| FLOT | AGENUS INC (AGEN) |
Frequently asked questions
How many drugs are in development for Resectable MMR-deficient Solid Tumors?
BioSniper tracks 1 drug in development for Resectable MMR-deficient Solid Tumors across 1 company.
How many clinical trials target Resectable MMR-deficient Solid Tumors?
There are 1 clinical trial targeting Resectable MMR-deficient Solid Tumors tracked by BioSniper.
Deep-dive into Resectable MMR-deficient Solid Tumors
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis